(Q62031419)

English

Glucose-Lowering Effects and Safety of Adding 0.25 or 0.5 mg Duvie

clinical trial

Statements

A Double Blind, Randomized, Investigator Initiated Study on Glucose-Lowering Effects and Safety of Adding 0.25 or 0.5 mg Duvie (Lobeglitazone) in Patients With Type 2 Diabetes With Inadequate Control on Metformin and DPP-4 Inhibitor Therapy (English)
0 references
20 December 2018
0 references
31 December 2020
0 references
174
0 references
19 year
0 references
80 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit